Eirik Høye

University of Oslo — Norway

Biochemistry, Genetics and Molecular Biology · Life Sciences

12h-index753citations30works8.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

MicroRNA in disease regulation(13), Cancer-related molecular mechanisms research(10), Colorectal Cancer Treatments and Studies(8), RNA modifications and cancer(7), Cancer Immunotherapy and Biomarkers(6)

Publications30 total

Abstract PR021: A cancer vaccine for de novo metastatic prostate cancer: learning patients stratification from the UV1 trial
Cancer Research·2026
Enrichment of Cancer‐Associated Fibroblasts, Macrophages, and Up‐Regulated <scp>TNF</scp> ‐α Signaling in the Tumor Microenvironment of <scp>CMS4</scp> Colorectal Peritoneal Metastasis
Cancer Medicine·2024· 3 citedOpen Access
MirGeneDB 3.0: improved taxonomic sampling, uniform nomenclature of novel conserved microRNA families and updated covariance models
Nucleic Acids Research·2024· 52 citedOpen Access
MirGeneDB 3.0: Improved taxonomic sampling, uniform nomenclature of novel conserved microRNA families, and updated covariance models
2024· 6 cited
543P Tumor mutational burden (TMB), BRAF status, and C-reactive protein (CRP) predict response to first-line alternating oxaliplatin-based chemotherapy and nivolumab in metastatic microsatellite-stable (MSS) colorectal cancer (CRC)
Annals of Oncology·2024Open Access
Insights into early animal evolution from the genome of the xenacoelomorph worm Xenoturbella bocki
eLife·2024· 13 citedOpen Access
Complete response of metastatic microsatellite-stable <i>BRAF</i> V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockade
OncoImmunology·2024· 3 citedOpen Access
Author response: Insights into early animal evolution from the genome of the xenacoelomorph worm Xenoturbella bocki
2024Open Access
Abstract 2522: Predictive value of tumor mutational burden (TMB) in patients with metastatic microsatellite-stable (MSS) colorectal cancer (CRC) given first-line oxaliplatin-based chemotherapy and immune checkpoint blockade (ICB)
Cancer Research·2024
T cell receptor repertoire sequencing reveals chemotherapy-driven clonal expansion in colorectal liver metastases
GigaScience·2022· 6 citedOpen Access
The slowly evolving genome of the xenacoelomorph worm <i>Xenoturbella bocki</i>
2022· 10 citedOpen Access
Abstract 1346: T cell receptor repertoire sequencing reveals chemotherapy-driven clonal expansion in colorectal liver metastases
Cancer Research·2022
A comprehensive framework for analysis of microRNA sequencing data in metastatic colorectal cancer
NAR Cancer·2022· 15 citedOpen Access
T Cell Receptor Repertoire Sequencing Reveals Chemotherapy-Driven Clonal Expansion in Colorectal Liver Metastases
SSRN Electronic Journal·2022· 1 citedOpen Access
MirGeneDB 2.1: toward a complete sampling of all major animal phyla
Nucleic Acids Research·2021· 162 citedOpen Access
MapToCleave: High-throughput profiling of microRNA biogenesis in living cells
Cell Reports·2021· 28 citedOpen Access
MapToCleave: high-throughput profiling of microRNA biogenesis in living cells
2021· 2 citedOpen Access
PO-1870: Distal esophageal cancer - should we use 3DCRT, IMRT or VMAT?
Radiotherapy and Oncology·2020
A microRNA Signature of Metastatic Colorectal Cancer
2020· 1 citedOpen Access
Neoadjuvant chemotherapy is associated with a transient increase of intratumoral T-cell density in microsatellite stable colorectal liver metastases
Cancer Biology & Therapy·2020· 43 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Bastian Fromm(19), Kjersti Flatmark(18), Eivind Hovig(13), Vegar Johansen Dagenborg(10), Åsmund Avdem Fretland(10), Bjørn Edwin(10), Anne Hansen Ree(9), Diana Domańska(8), Michael Hackenberg(8), Marc R. Friedländer(8), Vladimir Ovchinnikov(7), Morten Johansen(7), Kevin J. Peterson(7), Christin Lund‐Andersen(7), Susanne Lorenz(7), Wenjing Kang(6), Annette Torgunrud(6), Ernesto Aparicio‐Puerta(4), Anthony Mathelier(4), Inna Biryukova(4)